Publications Breadcrumb Home Publications Since we carefully research publications with DZIF affiliation before posting them on the DZIF website, there is usually a delay of two to three months between a paper's publication date and its listing on the DZIF publications website. Show filterHide filter All years of publication All years of publication20122013201420152016201720182019202020212022202320242025 All research areas All research areasCommunity-Acquired Infections at Mucosal InterfacesHepatitisHIVInfections of the Immunocompromised HostHealthcare-Associated InfectionsMalaria and Neglected Tropical DiseasesEmerging InfectionsNovel AntibioticsTuberculosis All infrastructures All infrastructuresBioresources, Biodata and Digital HealthDZIF AcademyClinical Trial UnitProduct Development Nov 2022 Eur J Med Chem Expanding the knowledge around antitubercular 5-(2-aminothiazol-4-yl)isoxazole-3-carboxamides: Hit-to-lead optimization and release of a novel antitubercular chemotype via scaffold derivatization Autoren Girardini M et al. Nov 2022 PLoS One Analysis of two choir outbreaks acting in concert to characterize long- range transmission risks through SARS-CoV-2, Berlin, Germany, 2020 Autoren Reichert F et al. Nov 2022 Infection Clinical features, treatment outcomes and mortality risk of tuberculosis sepsis in HIV-negative patients: a systematic review and meta-analysis of case reports Autoren Adegbite BR et al. Nov 2022 Sci Rep Diminished neutralization responses towards SARS-CoV-2 Omicron VoC after mRNA or vector-based COVID-19 vaccinations Autoren Jacobsen H et al. Nov 2022 Emerg Infect Dis Hepatitis E Virus Infections in Free-Ranging and Captive Cetaceans, Spain, 2011–2022 Autoren Caballero-Gómez J et al. Nov 2022 Front Microbiol Horizontal transfer and phylogenetic distribution of the immune evasion factor tarP Autoren Gerlach D et al. Nov 2022 Angew Chem Int Ed Engl Neutralizing the Impact of the Virulence Factor LecA from Pseudomonas aeruginosa on Human Cells with New Glycomimetic Inhibitors Autoren Zahorska E et al. Nov 2022 Pneumologie [Tuberculosis in adulthood - The Sk2-Guideline of the German Central Committee against Tuberculosis (DZK) and the German Respiratory Society (DGP) for the diagnosis and treatment of adult tuberculosis patients] Autoren Schaberg T et al. Nov 2022 Sci Immunol Exposure to BA.4/5 S protein drives neutralization of Omicron BA.1, BA.2, BA.2.12.1, and BA.4/5 in vaccine-experienced humans and mice Autoren Muik A et al. Nov 2022 Sci Rep Influence of tramadol on bacterial burden in the standard neutropenic thigh infection model Autoren Rox K Nov 2022 PLoS Biol SARS-CoV-2 variant Alpha has a spike-dependent replication advantage over the ancestral B.1 strain in human cells with low ACE2 expression Autoren Niemeyer D et al. Nov 2022 J Virol Methods A novel microarray-based PCR assay for the detection of HSV-1, HSV-2, and VZV skin infections: A retrospective analysis Autoren Dichtl K et al. Nov 2022 J Antimicrob Chemother EQUAL CPA Score 2022: a tool to measure guideline adherence for chronic pulmonary aspergillosis Autoren Sprute R et al. Nov 2022 Emerg Infect Dis Highly Diverse Arenaviruses in Neotropical Bats, Brazil Autoren Bentim Góes LG et al. Nov 2022 Clin Transplant Persisting dental foci increase the risk for bacterial infections before and after liver transplant Autoren Göbel P et al. Nov 2022 Nat Commun Reply to: The stress-inducible ER chaperone GRP78/BiP is upregulated during SARS-CoV-2 infection and acts as a pro-viral protein Autoren Shaban MS et al. Nov 2022 Int J Antimicrob Agents The evolution of carbapenem resistance determinants and major epidemiological lineages among carbapenem-resistant Acinetobacter baumannii isolates in Germany, 2010-2019 Autoren Wohlfarth E et al. Nov 2022 Commun Biol Multimeric ACE2-IgM fusions as broadly active antivirals that potently neutralize SARS-CoV-2 variants Autoren Svilenov HL et al. Nov 2022 J Clin Immunol Pathogenic Interleukin-10 Receptor Alpha Variants in Humans - Balancing Natural Selection and Clinical Implications Autoren Aschenbrenner D et al. Nov 2022 Med Microbiol Immunol Variable detection of Omicron-BA.1 and -BA.2 by SARS-CoV-2 rapid antigen tests Autoren Osterman A et al. Nov 2022 Lancet A revolution in the management of multidrug-resistant tuberculosis Autoren Dheda K Lange C Nov 2022 Microorganisms Broad Antiviral Effects of Echinacea purpurea against SARS-CoV-2 Variants of Concern and Potential Mechanism of Action Autoren Vimalanathan S et al. Nov 2022 Int J Mol Sci Different Involvement of Vimentin during Invasion by Listeria monocytogenes at the Blood-Brain and the Blood-Cerebrospinal Fluid Barriers In Vitro Autoren Banovic F et al. Nov 2022 Viruses Host Cell Entry and Neutralization Sensitivity of SARS-CoV-2 Lineages B.1.620 and R.1 Autoren Sidarovich A et al. Nov 2022 BMJ Open Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation: protocol for a multicentre, open-label, phase II, randomised controlled trial Autoren Morath C et al. Pagination Previous page ‹‹ Seite 86 Seite 87 Seite 88 Seite 89 Current page 90 Seite 91 Seite 92 Seite 93 Seite 94 Seite 86 Seite 87 Seite 88 Seite 89 Seite 90 Seite 91 Seite 92 Seite 93 Seite 94 Next page ››
Nov 2022 Eur J Med Chem Expanding the knowledge around antitubercular 5-(2-aminothiazol-4-yl)isoxazole-3-carboxamides: Hit-to-lead optimization and release of a novel antitubercular chemotype via scaffold derivatization Autoren Girardini M et al.
Nov 2022 PLoS One Analysis of two choir outbreaks acting in concert to characterize long- range transmission risks through SARS-CoV-2, Berlin, Germany, 2020 Autoren Reichert F et al.
Nov 2022 Infection Clinical features, treatment outcomes and mortality risk of tuberculosis sepsis in HIV-negative patients: a systematic review and meta-analysis of case reports Autoren Adegbite BR et al.
Nov 2022 Sci Rep Diminished neutralization responses towards SARS-CoV-2 Omicron VoC after mRNA or vector-based COVID-19 vaccinations Autoren Jacobsen H et al.
Nov 2022 Emerg Infect Dis Hepatitis E Virus Infections in Free-Ranging and Captive Cetaceans, Spain, 2011–2022 Autoren Caballero-Gómez J et al.
Nov 2022 Front Microbiol Horizontal transfer and phylogenetic distribution of the immune evasion factor tarP Autoren Gerlach D et al.
Nov 2022 Angew Chem Int Ed Engl Neutralizing the Impact of the Virulence Factor LecA from Pseudomonas aeruginosa on Human Cells with New Glycomimetic Inhibitors Autoren Zahorska E et al.
Nov 2022 Pneumologie [Tuberculosis in adulthood - The Sk2-Guideline of the German Central Committee against Tuberculosis (DZK) and the German Respiratory Society (DGP) for the diagnosis and treatment of adult tuberculosis patients] Autoren Schaberg T et al.
Nov 2022 Sci Immunol Exposure to BA.4/5 S protein drives neutralization of Omicron BA.1, BA.2, BA.2.12.1, and BA.4/5 in vaccine-experienced humans and mice Autoren Muik A et al.
Nov 2022 Sci Rep Influence of tramadol on bacterial burden in the standard neutropenic thigh infection model Autoren Rox K
Nov 2022 PLoS Biol SARS-CoV-2 variant Alpha has a spike-dependent replication advantage over the ancestral B.1 strain in human cells with low ACE2 expression Autoren Niemeyer D et al.
Nov 2022 J Virol Methods A novel microarray-based PCR assay for the detection of HSV-1, HSV-2, and VZV skin infections: A retrospective analysis Autoren Dichtl K et al.
Nov 2022 J Antimicrob Chemother EQUAL CPA Score 2022: a tool to measure guideline adherence for chronic pulmonary aspergillosis Autoren Sprute R et al.
Nov 2022 Emerg Infect Dis Highly Diverse Arenaviruses in Neotropical Bats, Brazil Autoren Bentim Góes LG et al.
Nov 2022 Clin Transplant Persisting dental foci increase the risk for bacterial infections before and after liver transplant Autoren Göbel P et al.
Nov 2022 Nat Commun Reply to: The stress-inducible ER chaperone GRP78/BiP is upregulated during SARS-CoV-2 infection and acts as a pro-viral protein Autoren Shaban MS et al.
Nov 2022 Int J Antimicrob Agents The evolution of carbapenem resistance determinants and major epidemiological lineages among carbapenem-resistant Acinetobacter baumannii isolates in Germany, 2010-2019 Autoren Wohlfarth E et al.
Nov 2022 Commun Biol Multimeric ACE2-IgM fusions as broadly active antivirals that potently neutralize SARS-CoV-2 variants Autoren Svilenov HL et al.
Nov 2022 J Clin Immunol Pathogenic Interleukin-10 Receptor Alpha Variants in Humans - Balancing Natural Selection and Clinical Implications Autoren Aschenbrenner D et al.
Nov 2022 Med Microbiol Immunol Variable detection of Omicron-BA.1 and -BA.2 by SARS-CoV-2 rapid antigen tests Autoren Osterman A et al.
Nov 2022 Lancet A revolution in the management of multidrug-resistant tuberculosis Autoren Dheda K Lange C
Nov 2022 Microorganisms Broad Antiviral Effects of Echinacea purpurea against SARS-CoV-2 Variants of Concern and Potential Mechanism of Action Autoren Vimalanathan S et al.
Nov 2022 Int J Mol Sci Different Involvement of Vimentin during Invasion by Listeria monocytogenes at the Blood-Brain and the Blood-Cerebrospinal Fluid Barriers In Vitro Autoren Banovic F et al.
Nov 2022 Viruses Host Cell Entry and Neutralization Sensitivity of SARS-CoV-2 Lineages B.1.620 and R.1 Autoren Sidarovich A et al.
Nov 2022 BMJ Open Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation: protocol for a multicentre, open-label, phase II, randomised controlled trial Autoren Morath C et al.
